Iovance Biotherapeutics Inc (IOVA)
8.24
+0.10
(+1.23%)
USD |
NASDAQ |
Nov 21, 16:00
8.20
-0.04
(-0.49%)
After-Hours: 20:00
Iovance Biotherapeutics Gross Profit Margin (Quarterly): 31.99% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 31.99% |
| June 30, 2024 | -0.84% |
| March 31, 2024 | -915.5% |
| Date | Value |
|---|---|
| December 31, 2023 | -805.6% |
| September 30, 2023 | -825.4% |
| June 30, 2023 | -761.3% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-915.5%
Minimum
Mar 2024
31.99%
Maximum
Sep 2024
-546.1%
Average
-783.5%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 78.34% |
| Xtant Medical Holdings Inc | 58.37% |
| Myomo Inc | 75.43% |
| Catheter Precision Inc | 89.58% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -58.90% |
| Return on Assets | -45.99% |
| Return on Invested Capital | -58.81% |
| Profit Margin (Quarterly) | -142.7% |
| Operating Margin (Quarterly) | -152.1% |
| Return on Net Operating Assets | -84.05% |